The use of high-dose dual-impregnated antibiotic-laden cement with hemiarthroplasty for the treatment of a fracture of the hip: The Fractured Hip Infection trial

A P Sprowson, C Jensen, S Chambers, N R Parsons, N M Aradhyula, I Carluke, D Inman, M R Reed, A P Sprowson, C Jensen, S Chambers, N R Parsons, N M Aradhyula, I Carluke, D Inman, M R Reed

Abstract

Aims: A fracture of the hip is the most common serious orthopaedic injury, and surgical site infection (SSI) is one of the most significant complications, resulting in increased mortality, prolonged hospital stay and often the need for further surgery. Our aim was to determine whether high dose dual antibiotic impregnated bone cement decreases the rate of infection.

Patients and methods: A quasi-randomised study of 848 patients with an intracapsular fracture of the hip was conducted in one large teaching hospital on two sites. All were treated with a hemiarthroplasty. A total of 448 patients received low dose single-antibiotic impregnated cement (control group) and 400 patients received high dose dual-antibiotic impregnated cement (intervention group). The primary outcome measure was deep SSI at one year after surgery.

Results: The rate of deep SSI was 3.5% in the control group and 1.1% in the intervention group (p = 0.041; logistic regression adjusting for age and gender). The overall rate of non-infective surgical complications did not differ between the two groups (unadjusted chi-squared test; p > 0.999).

Conclusion: The use of high dose dual-antibiotic impregnated cement in these patients significantly reduces the rate of SSI compared with standard low dose single antibiotic loaded bone cement. Cite this article: Bone Joint J 2016;98-B:1534-1541.

Keywords: Antibiotics; Cement; Fractured neck of femur; Randomised; Trial.

©2016 Reed et al.

Figures

Fig. 1
Fig. 1
30 day questionnaire designed by the English Health Protection Agency (now Public Health England).
Fig. 2
Fig. 2
Overall flow of patients in the Fractured Hip Infection Trial.

References

    1. Jameson SS, Khan SK, Baker P, et al. A national analysis of complications following hemiarthroplasty for hip fracture in older patients. QJM 2012;105:455–460.
    1. Burge R, Worley D, Johansen A, Bose U. The cost of osteoporotic fractures in the UK: Projections for 2000-2020. J Medical Economics 2008;4:51–62.
    1. No authors listed. The National Hip Fracture Database. (date last accessed 27 September 2016).
    1. Parker MJ, Gurusamy KS, Azegami S. Arthroplasties (with and without bone cement) for proximal femoral fractures in adults. Cochrane Database Syst Rev 2010;CD001706.
    1. Leaper DJ, Tanner J, Kiernan M, Assadian O, Edmiston CE Jr. Surgical site infection: poor compliance with guidelines and care bundles. Int Wound J 2015;12:357–362.
    1. Coello R, Charlett A, Wilson J, et al. Adverse impact of surgical site infections in English hospitals. J Hosp Infect 2005;60:93–103.
    1. Gjertsen JE, Lie SA, Vinje T, et al. More re-operations after uncemented than cemented hemiarthroplasty used in the treatment of displaced fractures of the femoral neck: an observational study of 11,116 hemiarthroplasties from a national register. J Bone Joint Surg [Br] 2012;94-B:1113–1119.
    1. Westberg M, Snorrason F, Frihagen F. Preoperative waiting time increased the risk of periprosthetic infection in patients with femoral neck fracture. Acta Orthop 2013;84:124–129.
    1. Wilson J, Charlett A, Leong G, McDougall C, Duckworth G. Rates of surgical site infection after hip replacement as a hospital performance indicator: analysis of data from the English mandatory surveillance system. Infect Control Hosp Epidemiol 2008;29:219–226.
    1. Hill C, Flamant R, Mazas F, Evrard J. Prophylactic cefazolin versus placebo in total hip replacement. Report of a multicentre double-blind randomised trial. Lancet 1981;1:795–796.
    1. Engesaeter LB, Lie SA, Espehaug B, et al. Antibiotic prophylaxis in total hip arthroplasty: effects of antibiotic prophylaxis systemically and in bone cement on the revision rate of 22,170 primary hip replacements followed 0-14 years in the Norwegian Arthroplasty Register. Acta Orthop Scand 2003;74:644–651.
    1. Jameson SS, Jensen CD, Elson DW, et al. Cemented versus cementless hemiarthroplasty for intracapsular neck of femur fracture--a comparison of 60,848 matched patients using national data. Injury 2013;44:730–734.
    1. No authors listed. The Care of Patients with Fagility Fracture. (date last accessed 27 September 2016).
    1. Patel NK, Sarraf KM, Joseph S, Lee C, Middleton FR. Implementing the National Hip Fracture Database: an audit of care. Injury 2013;44:1934–1939.
    1. Middleton RG, Uzoigwe CE, Young PS, et al. Peri-operative mortality after hemiarthroplasty for fracture of the hip: does cement make a difference? Bone Joint J 2014;96-B:1185–1191.
    1. Khunda A, Jafari M, Alazzawi S, Mountain A, Hui AC. Mortality and re-operation rate after proximal femoral fracture surgery by trainees. J Orthop Surg (Hong Kong) 2013;21:87–91.
    1. Poór G, Atkinson EJ, O'Fallon WM, Melton LJ 3rd. Determinants of reduced survival following hip fractures in men. Clin Orthop Relat Res 1995;319:260–265.
    1. No authors listed. Rapid Response Report: Mitigating surgical risk in patients undergoing hip arthroplasty for fractures of the proximal femur. (date last accessed 27 September 2016).
    1. Vestergaard P, Rejnmark L, Mosekilde L. Increased mortality in patients with a hip fracture-effect of pre-morbid conditions and post-fracture complications. Osteoporos Int 2007;18:1583–1593.
    1. Sprowson AP, Jensen CD, Gupta S, et al. The effect of high dose antibiotic impregnated cement on rate of surgical site infection after hip hemiarthroplasty for fractured neck of femur: a protocol for a double-blind quasi randomised controlled trial. BMC Musculoskelet Disord 2013;14:356.
    1. Vijayananthan A, Nawawi O. The importance of Good Clinical Practice guidelines and its role in clinical trials. Biomed Imaging Interv J 2008;4:5.
    1. Ensing GT, van Horn JR, van der Mei HC, Busscher HJ, Neut D. Copal bone cement is more effective in preventing biofilm formation than Palacos R-G. Clin Orthop Relat Res 2008;466:1492–1498.
    1. Sprowson A, Symes T, Khan SK, Oswald T, Reed MR. Changing antibiotic prophylaxis for primary joint arthroplasty affects postoperative complication rates and bacterial spectrum. Surgeon 2013;11:20–24.
    1. No authors listed. Surgical site infection surveillance service: protocol, procedure codes and user manual. (date last accessed 27 September 2016).
    1. Turina M, Fry DE, Polk HC Jr. Acute hyperglycemia and the innate immune system: clinical, cellular, and molecular aspects. Crit Care Med 2005;33:1624–1633.
    1. Moucha CS, Clyburn T, Evans RP, Prokuski L. Modifiable risk factors for surgical site infection. J Bone Joint Surg [Am] 2011;93-A:398–404.
    1. Dean CB, Nielsen JD. Generalized linear mixed models: a review and some extensions. Lifetime Data Anal 2007;13:497–512.
    1. Jameson SS, Lees D, James P, et al. Cemented hemiarthroplasty or hip replacement for intracapsular neck of femur fracture? A comparison of 7732 matched patients using national data. Injury 2013;44:1940–1944.
    1. Saklad M. Grading of patients for surgical procedures. Anesthesiol 1941;2:281–284.
    1. Charnley J. A sterile-air operating theatre enclosure. Br J Surg 1964;51:195–202.
    1. Franco JA, Baer H, Enneking WF. Airborne contamination in orthopedic surgery. Evaluation of laminar air flow system and aspiration suit. Clin Orthop Relat Res 1977;122:231–243.
    1. Darouiche RO, Wall MJ Jr, Itani KM, et al. Chlorhexidine-Alcohol versus Povidone-Iodine for Surgical-Site Antisepsis. N Engl J Med 2010;362:18–26.
    1. Tanner J, Parkinson H. Double gloving to reduce surgical cross-infection. Cochrane Database Syst Rev 2006;3:CD003087.
    1. Classen DC, Evans RS, Pestotnik SL, et al. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med 1992;326:281–286.
    1. Gorbach SL, Condon RE, Conte JE Jr, et al. Evaluation of new anti-infective drugs for surgical prophylaxis. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis 1992;15:S313–S338.
    1. Buchholz HW, Elson RA, Engelbrecht E, et al. Management of deep infection of total hip replacement. J Bone Joint Surg [Br] 1981;63-B:342–353.
    1. Chang Y, Tai CL, Hsieh PH, Ueng SW. Gentamicin in bone cement: A potentially more effective prophylactic measure of infection in joint arthroplasty. Bone Joint Res 2013;2:220–226.
    1. Periti P, Stringa G, Mini E. Comparative multicenter trial of teicoplanin versus cefazolin for antimicrobial prophylaxis in prosthetic joint implant surgery. Italian Study Group for Antimicrobial Prophylaxis in Orthopedic Surgery. Eur J Clin Microbiol Infect Dis 1999;18:113–119.
    1. Wang J, Zhu C, Cheng T, et al. A systematic review and meta-analysis of antibiotic-impregnated bone cement use in primary total hip or knee arthroplasty. PLoS One 2013;8:82745.
    1. Nelissen RG, Garling EH, Valstar ER. Influence of cement viscosity and cement mantle thickness on migration of the Exeter total hip prosthesis. J Arthroplasty 2005;20:521–528.
    1. Jämsen E, Furnes O, Engesaeter LB, et al. Prevention of deep infection in joint replacement surgery. Acta Orthop 2010;81:660–666.
    1. Josefsson G, Kolmert L. Prophylaxis with systematic antibiotics versus gentamicin bone cement in total hip arthroplasty. A ten-year survey of 1,688 hips. Clin Orthop Relat Res 1993;292:210–214.
    1. Josefsson G, Lindberg L, Wiklander B. Systemic antibiotics and gentamicin-containing bone cement in the prophylaxis of postoperative infections in total hip arthroplasty. Clin Orthop Relat Res 1981;159:194–200.
    1. Fink B, Vogt S, Reinsch M, Büchner H. Sufficient release of antibiotic by a spacer 6 weeks after implantation in two-stage revision of infected hip prostheses. Clin Orthop Relat Res 2011;469:3141–3147.
    1. Thomes B, Murray P, Bouchier-Hayes D. Development of resistant strains of Staphylococcus epidermidis on gentamicin-loaded bone cement in vivo. J Bone Joint Surg [Br] 2002;84-B:758–760.
    1. Neut D, van de Belt H, van Horn JR, van der Mei HC, Busscher HJ. Residual gentamicin-release from antibiotic-loaded polymethylmethacrylate beads after 5 years of implantation. Biomaterials 2003;24:1829–1831.
    1. Kendall RW, Duncan CP, Smith JA, Ngui-Yen JH. Persistence of bacteria on antibiotic loaded acrylic depots. A reason for caution. Clin Orthop Relat Res 1996;329:273–280.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe